As of May 14, 2026, the CDC reports 1,893 confirmed measles cases in the United States this year—a 51-case increase from the prior week—spanning 27 outbreaks across 40 jurisdictions, with 93% outbreak-associated primarily due to importations from global transmission hotspots into under-vaccinated communities. Declining MMR vaccine coverage (92.5% among kindergarteners, down from 95.2% pre-pandemic) heightens susceptibility, as the virus's high transmissibility (R0 of 12–18) enables rapid spread without herd immunity thresholds met locally. Trader sentiment hinges on weekly CDC surveillance updates (Thursdays at 12 PM ET), state reports, and public health responses, with potential for more cases by May 31 amid ongoing risks despite recent containments like South Carolina's ended outbreak.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · ActualizadoMeasles cases in U.S. by May 31?
Measles cases in U.S. by May 31?
$59,686 Vol.
31 may 2026
1900
94%
1925
91%
1950
51%
2000
5%
2200
3%
2400
1%
$59,686 Vol.
1900
$24,923 Vol.
94%
1925
$3,580 Vol.
91%
1950
$11,390 Vol.
51%
2000
$11,418 Vol.
5%
2200
$2,644 Vol.
3%
2400
$950 Vol.
1%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by May 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of May 14, 2026, the CDC reports 1,893 confirmed measles cases in the United States this year—a 51-case increase from the prior week—spanning 27 outbreaks across 40 jurisdictions, with 93% outbreak-associated primarily due to importations from global transmission hotspots into under-vaccinated communities. Declining MMR vaccine coverage (92.5% among kindergarteners, down from 95.2% pre-pandemic) heightens susceptibility, as the virus's high transmissibility (R0 of 12–18) enables rapid spread without herd immunity thresholds met locally. Trader sentiment hinges on weekly CDC surveillance updates (Thursdays at 12 PM ET), state reports, and public health responses, with potential for more cases by May 31 amid ongoing risks despite recent containments like South Carolina's ended outbreak.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by May 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Mercado abierto: Apr 28, 2026, 6:09 PM ET
Volumen
$59,686Fecha de finalización
31 may 2026Mercado abierto
Apr 28, 2026, 6:09 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by May 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of May 14, 2026, the CDC reports 1,893 confirmed measles cases in the United States this year—a 51-case increase from the prior week—spanning 27 outbreaks across 40 jurisdictions, with 93% outbreak-associated primarily due to importations from global transmission hotspots into under-vaccinated communities. Declining MMR vaccine coverage (92.5% among kindergarteners, down from 95.2% pre-pandemic) heightens susceptibility, as the virus's high transmissibility (R0 of 12–18) enables rapid spread without herd immunity thresholds met locally. Trader sentiment hinges on weekly CDC surveillance updates (Thursdays at 12 PM ET), state reports, and public health responses, with potential for more cases by May 31 amid ongoing risks despite recent containments like South Carolina's ended outbreak.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by May 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volumen
$59,686Fecha de finalización
31 may 2026Mercado abierto
Apr 28, 2026, 6:09 PM ETResolver
0x65070BE91...As of May 14, 2026, the CDC reports 1,893 confirmed measles cases in the United States this year—a 51-case increase from the prior week—spanning 27 outbreaks across 40 jurisdictions, with 93% outbreak-associated primarily due to importations from global transmission hotspots into under-vaccinated communities. Declining MMR vaccine coverage (92.5% among kindergarteners, down from 95.2% pre-pandemic) heightens susceptibility, as the virus's high transmissibility (R0 of 12–18) enables rapid spread without herd immunity thresholds met locally. Trader sentiment hinges on weekly CDC surveillance updates (Thursdays at 12 PM ET), state reports, and public health responses, with potential for more cases by May 31 amid ongoing risks despite recent containments like South Carolina's ended outbreak.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes